From: Suitability assessment of baseline concentration of MMP3, TIMP3, HE4 and CA125 in the serum of patients with ovarian cancer
MMP3
TIMP3
HE4
CA125
sensitivity
68%
79%
84%
75%
specificity
69%
78%
92%
80%
sensitivity PM
67%
88%
specificity PM
70%
76%
94%
sensitivity M
66%
86%
specificity M
65%
85%
81%